Rhythm CMO granted 50,000 stock options, RSUs
RHYTHM PHARMACEUTICALS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported that Chief Medical Officer Manher Joshi received equity awards. He was granted 50,000 stock options with an exercise price of $115.44 per share, expiring August 16, 2036. These options vest 25% after one year, then 6.25% every three months of continued service.
He also received 25,000 Restricted Stock Units, vesting 25% on September 1 of each of 2027, 2028, 2029, and 2030, becoming fully vested on September 1, 2030, subject to continued service. Following these grants, he holds 50,000 options and 25,000 RSUs directly.
Insider Trade Summary
Grant/Award: 75,000 shares
Grant/Award
2 txns
Insider
Joshi Manher
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) F1 | 50,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F2, F3 | 25,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 50,000 contracts (Direct);
Restricted Stock Units — 25,000 contracts (Direct)
Footnotes (3)
- F1. The Stock Options vest and become exercisable as to 25% of the total number of shares subject to the option on the first anniversary of the grant date and as to 6.25% of the total number of shares subject to the option upon the Reporting Person's completion of each successive three months of service to the Corporation.
- F2. The Restricted Stock Units vest as to 25% of the Restricted Stock Units on September 1 of each of 2027, 2028, 2029, and 2030, such that the Restricted Stock Units shall be fully vested on September 1, 2030, subject to the Reporting Person continuing in service through each such vesting date.
- F3. The restricted stock units have no expiration date.
Key Figures
Stock options granted: 50,000 shares
Option exercise price: $115.44 per share
Option expiration: August 16, 2036
+3 more
6 metrics
Stock options granted
50,000 shares
Stock Options (Right to Buy) granted to Chief Medical Officer on August 17, 2026
Option exercise price
$115.44 per share
Conversion or exercise price for 50,000 stock options granted
Option expiration
August 16, 2036
Expiration date of the stock options granted to Manher Joshi
RSUs granted
25,000 units
Restricted Stock Units granted to Chief Medical Officer on August 17, 2026
Options after transaction
50,000 shares
Total stock options held directly by the reporting person following the grant
RSUs after transaction
25,000 units
Total Restricted Stock Units held directly by the reporting person following the grant
Key Terms
Stock Options (Right to Buy), Restricted Stock Units, exercise price, vesting
4 terms
Stock Options (Right to Buy) financial
"The security title is listed as Stock Options (Right to Buy)"
Restricted Stock Units financial
"The security title is listed as Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"Conversion or exercise price is stated as 115.4400 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The Stock Options vest and become exercisable as to 25% of the total number"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did RYTM grant to Chief Medical Officer Manher Joshi?
RHYTHM PHARMACEUTICALS granted Manher Joshi 50,000 stock options and 25,000 Restricted Stock Units (RSUs) on August 17, 2026. The options have a set exercise price and long-term vesting, while the RSUs vest annually from 2027 through 2030, subject to continued service.
What is the exercise price and term of the new stock options reported for RYTM?
The newly granted stock options carry an exercise price of $115.44 per share and expire on August 16, 2036. They vest 25% after one year from grant, then 6.25% every three months of continued service at Rhythm Pharmaceuticals.
How do the RSUs granted to Manher Joshi at RYTM vest over time?
The 25,000 RSUs vest as to 25% on September 1 of each year 2027, 2028, 2029, and 2030. All units are fully vested by September 1, 2030, provided Joshi continues in service through each vesting date.
How many derivative securities does Manher Joshi hold in RYTM after these grants?
After these grants, Manher Joshi directly holds 50,000 stock options and 25,000 RSUs linked to Rhythm Pharmaceuticals common stock. These holdings represent potential future ownership, contingent on vesting and, for options, on exercising at the stated price.
Are the RSUs granted by RYTM to Manher Joshi subject to an expiration date?
The filing states that the restricted stock units have no expiration date. They are instead governed by their vesting schedule, which runs from September 1, 2027 through September 1, 2030, assuming continued service at Rhythm Pharmaceuticals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
